ANG-1623

N/A

Report date: 2025/01/26 19:06:59
NME

Base Information

Drug NameANG-1623
Drug Alias NameENPP1 antagonist (Angarus/Stanford University)ectonucleotide pyrophosphatase 1 inhibitor (Angarus/Stanford University)ANG-1623
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEctonucleotide Pyrophosphatase/Phosphodiesterase 1 inhibitors
TargetsEctonucleotide Pyrophosphatase/Phosphodiesterase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAngarus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAngarus Therapeutics IncStanford University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A